Top Banner
APPROACH TO HEMOLYTIC ANEMIA Dr NAGLAA MAKRAM CONSULTANT CLINICAL PATHOLOGY
61
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Approach to hemolytic anemia naglaa

APPROACH TO HEMOLYTIC ANEMIA

Dr NAGLAA MAKRAM

CONSULTANT CLINICAL PATHOLOGY

Page 2: Approach to hemolytic anemia naglaa

OBJECTIVES

Lab indication of hemolysis

Intravascular v/s extravascular hemolysis

D/D of hemolytic anemia

Diagnose hemo. anemia with peripheral smear &

ancillary lab tests

Page 3: Approach to hemolytic anemia naglaa

1ST STEP IN APPROACH TO HAEMOLYTIC ANEMIA

1. Check the reticulocyte count to determine if the anemia is from decreased production (“hypoproliferative”, “reticulocytopenic”) or increased destruction (“hemolytic”)/acute blood loss (“reticulocytosis”)

3. If the the reticulocyte count is increased- Check a direct Coomb’s test

4. Look at the peripheral blood smear to confirm/support the diagnosis

Page 4: Approach to hemolytic anemia naglaa

ANEMIA ALGORITHM, CONTINUED Patient with anemia and increased reticulocyte count-

What is the result of a Coomb’s test ??

Extrinsic red cell defect

Vessel Valve

Toxin

Negative Positive (autoimmune hemolytic

anemia)

Intrinsic red cell defect

Membrane

Hemoglobin

Cytoplasm

“Warm” “Cold”

Page 5: Approach to hemolytic anemia naglaa

Random hemolysis—: 

 In addition to the death of aging (senescent) red blood cells (RBCs), there is age-independent RBC destruction (random hemolysis) in normal subjects in range of less than 0.05 to 0.5 percent per day.

When hemolysis occurs, the degree of anemia is minimized by a compensatory increase in the secretion of erythropoietin (EPO), which enhances RBC production .

This response is manifested initially by an increase in the reticulocyte percentage and absolute reticulocyte count, followed by an increase in hemoglobin (Hgb) concentration.

Page 6: Approach to hemolytic anemia naglaa

HOW IS HEMOLYTIC ANEMIA DIAGNOSED?

Two main principles

One is to confirm that it is hemolysis

Two is to determine the etiology

Page 7: Approach to hemolytic anemia naglaa

FINDINGS IN HEMOLYTIC ANEMIA

HEMOGLOBIN FROM NORMAL TO SEVERELY REDUCED

MCV USUALLY INCREASED

Reticulocyte count and RPI Increased

Serum Unconjugated Bilirubin Increased

Serum LDH 1: LDH 2 Increased

Serum Haptoglobin Decreased

Urine Hemoglobin Present

Urine Hemosiderin Present

Urine Urobilinogen IncreasedCr 51 labeled RBC life span Decreased

Acid hemolysis test (PNH)

Page 8: Approach to hemolytic anemia naglaa

LAB FINDINGS AND INVESTIGATIONS

Assess Iron Overload via :

• Serum iron level is elevated, with saturation as high as 80%.

• ferritin and transferrin – elevated

• Aim: Serum ferritin <1000ng/ml.

Red cell phenotyping (ideal)–transfusion

Page 9: Approach to hemolytic anemia naglaa

Extravascular Intravascular  

HEMATOLOGIC

Routine blood film

Reticulocyte count

Bone marrow examination

Polychromatophilia

Erythroid hyperplasia

Polychromatophilia

Erythroid hyperplasia  

PLASMA OR SERUM

Bilirubin

Haptoglobin

Plasma hemoglobin

Lactate dehydrogenase

Unconjugated

, Absent

N/

(Variable)

Unconjugated

Absent

(Variable)

 

URINE

BilirubinHemosiderinHemoglobin

+00

+++ severe cases

 

Page 10: Approach to hemolytic anemia naglaa

POLYCHROMATOPHILIC CELLS

Page 11: Approach to hemolytic anemia naglaa

[email protected]

CORRECTING RETIC COUNT

Retic Index = Retic % x Patient Hct Normal Hct

Absolute Retic = Retic % x RBC/mm3

Retic Production Index = Retic Index Days in circulation

Page 12: Approach to hemolytic anemia naglaa

THE KEY TO THE ETIOLOGY OF HEMOLYTIC ANEMIA

The history

The peripheral blood film

Page 13: Approach to hemolytic anemia naglaa

CASE 1

3 yr old male child presenting with pallor, jaundice,

Severe pain of long bones, fever CBC-anemia ,reticulocytosis , increased WBC LAB - LDH -600 (normal upto 200) S. bilirubin- 5 mg%

Page 14: Approach to hemolytic anemia naglaa

PERIPHERAL SMEAR

Page 15: Approach to hemolytic anemia naglaa

DIAGNOSIS – OTHER TESTSSICKLING TEST :

It should not be performed on infants until they are at least 6 month old because of the presence of hemoglobin F as the predominant hemoglobin at birth , therefore, this test may give a false-negative result if performed too early (if hemoglobin S is <10%).

Recent blood transfusions, typically within the last three months of the date of testing, may cause a false-negative test result .

False positive results may be due to polycythaemic , high proteins and a variety of abnormal haemoglobins including Hb’s I, Bart’s, C-Georgetown, Alexandra and C-Harlem.

Page 16: Approach to hemolytic anemia naglaa

Hemoglobin electrophoresis

Hemoglobin fractionation by HPLC, the most frequently used method to screen for hemoglobin variants, including Hb S .

Isoelectric focusing, a highly sensitive method that is often used at large reference laboratories .

Page 17: Approach to hemolytic anemia naglaa

CLINICAL FEATURES OF SICKLE HEMOGLOBINOPATHIES

Condition Clinical abnorm

Hb level g% MCV,fl Hb electropho

Sickle cell trait

None,rare painlss hematuria

normal normal HbS/A: 40/60

Sickle cell anemia

Vasocclusive crises,AVN,gallstones, priapism

7-10 80-100 HbS/A:100/0

S/beta0thalasssemia

VasoocclusiveCrises,AVN

7-10 60-80 HbS/A-100/0HbF; 1-10%

S/beta+ thalassemia

Rare crises,AVN

10-14 70-80 HbS/A:60/40

HbSC --do--, retinopathy

10-14 80-100 HbS/A;50/0HbC;50%

Page 18: Approach to hemolytic anemia naglaa

DNA analysis :

This test is used to investigate alterations and mutations in the genes that produce hemoglobin components.

It may be performed to determine whether someone has one or two copies of the Hb S mutation or has two different mutations in hemoglobin genes (e.g., Hb S and Hb C).

Genetic counseling :used for prenatal testing: amniotic fluid may be tested at 14 to 16 weeks to provide a definitive answer. It can also be performed earlier with chorionic villus sampling.

Page 19: Approach to hemolytic anemia naglaa

DIAGNOSIS?

SICKLE THALASSEMIA`

Page 20: Approach to hemolytic anemia naglaa

CASE 2

6 yr old child presenting with severe pallor , jaundice growth delay

Abnormal facies , hepatosplenomegaly+ h/o recurrent blood transfusions CBC-Hb -3gm%, MCV-58FL, -MCH- 19pg (nl-28-33) P.S- MICROCYTIC,HYPOCHROMIA with target cells +

Page 21: Approach to hemolytic anemia naglaa

DIAGNOSIS?

Page 22: Approach to hemolytic anemia naglaa

TARGET CELLS

Page 23: Approach to hemolytic anemia naglaa

Distinguishing thalassaemia minor from IDA from CBC by applying formulae:

Formula Thal. IDA

MCV RCC (Mentzer index) <13 >13

MCH RCC < 3.8 > 3.8

(MCV2 MCH) 100 < 1530 > 1530

MCV – RCC – (Hb 5) – 3.4 < 0 > 0

(MCV2 RDW) (100xHb) < 65 > 65

RDW-CV% <14.6 >14.6

Page 24: Approach to hemolytic anemia naglaa

Comparison of β Thalassemias

Parameter Minor Intermedia MajorHb 10-13 6-10 2-8MCV (fl) 60-78 50-70 50-60MCH (pg) 28-32 22-28 16-22RDW Normal S. increased IncreasedMicro/hypo Film Mild Moderate SeverePolychromasia V. Little Moderate MarkedAnisocytosis None Moderate MarkedPoikilocytosis None Moderate MarkedTargetting Present Present Present

Page 25: Approach to hemolytic anemia naglaa

25

COMPARISON OF BETA THALASSEMIAS

GENOTYPE HGB A HGB A2 HGB F

NORMAL Normal Normal Normal

MINOR 80-95%, 3.5-7.5% 1-5%

INTERMEDIA

0-30% 3.5%-5.5%

20-70%

MAJOR 0 % 3.5 %- 5.5%

90-96 %

DNA analysis for mutations

Globin Chain Testing - determines ratio of globin chains being produced.

Page 26: Approach to hemolytic anemia naglaa

ALPHA THALASSEMIAS

disease Hb A %

HbH %

Hb , % MCV,fl

Normal α,α/α,α 97 0 15 90

Thalassemia traits(genotype α,-/α,α)

90-95 rare 12-13 70-80

HbH (b4) (genotype α,-/-,-) 70-95 5-30 6-10 60-70

Hb Bart (genotype -,-/-,-)(hydrops fetalis)

0 5-10 Fatal inutero or at birth

α+ thalassaemia homozygous (genotype α,-/α,-)αo thalassaemia heterozygous (genotype α,α/,--)

Page 27: Approach to hemolytic anemia naglaa

HB-BART’S

Is only detected at birth. But then disappears (WHY???). So diagnosis of alpha thalassemia could be established at birth directly in comparison of beta thalassemia.

Page 28: Approach to hemolytic anemia naglaa

ALPHA THALASSEMIA WITH BASOPHILIC STIPPLING

Page 29: Approach to hemolytic anemia naglaa

HB-H PREPARATION

Same preparation as Retic count stain, but with extended time of incubation, instead of 15 minutes, 2 hours incubation is required.

Page 30: Approach to hemolytic anemia naglaa

Hydrops Fetalis

The blood film of neonate with hemoglobin Bart’s hydrops fetalis showing anisocytosis, poikilocytosis and numerous nucleated red blood cells (NRBC).

Page 31: Approach to hemolytic anemia naglaa

CASE 3

45 yr old male came to OPD in a remote PHC with burning micturition

Urine R/M shows numerous pus cells++++ UTI diagnosed & medical officer gave cotrimoxazole 2

bd X 5days 1 wk later,pt developed severe

pallor,palpitation,jaundice

Lab- increased LDH, S.BILIRUBIN, RETIC COUNT P.S- shows irreg cells like

Page 32: Approach to hemolytic anemia naglaa
Page 33: Approach to hemolytic anemia naglaa

BLISTER CELLS

Page 34: Approach to hemolytic anemia naglaa

HEINZ BODIES

Page 35: Approach to hemolytic anemia naglaa

DIAGNOSIS?

G-6PD DEFICIENCY

INVESTIGATION-• Peripheral smear: bite cells , heinz bodies -

polychromasia

• G-6PD LEVEL

Quantitative , qualitative , PCR

Page 36: Approach to hemolytic anemia naglaa

Patients with acute hemolysis, testing for G6PD deficiency may be falsely negative because older erythrocytes with a higher enzyme deficiency have been hemolyzed.

Young erythrocytes and reticulocytes have normal or near-normal enzyme activity.

Female heterozygotes may be hard to diagnose because of X-chromosome mosaicism leading to a partial deficiency that will not be detected reliably with screening tests.

G6PD deficiency should be considered in neonates who develop hyperbilirubinemia

Page 37: Approach to hemolytic anemia naglaa

Pyruvate Kinase Deficiency

Deficient ATP production, Chronic hemolytic anemia

Inv;P. Smear: PRICKLE CELLS ( Contracted rbc with

spicules)

Decreased enzyme activity

Page 38: Approach to hemolytic anemia naglaa

PRICKLE CELL

Page 39: Approach to hemolytic anemia naglaa

CASE 4

14 YR old female present with anemia, jaundice Rt hypochondrial pain o/e- vitals stable.pallor+,icterus+,splenomegaly

+ Usg- cholilithiasis

Lab; elevated LDH, S.Bilirubin , reticulocyte count   MCHC, ,  RDW decreased Hb,  MCV.

Peripheral smear shows- hyperdense cells

Page 40: Approach to hemolytic anemia naglaa
Page 41: Approach to hemolytic anemia naglaa

DIFFERENTIAL DIAGNOSIS

Hereditary spherocytosis

Autoimmune hemolytic anemia

Other diagnostic tests- osmotic fragility - coombs test

The acid glycerol lysis test Screen family members

Page 42: Approach to hemolytic anemia naglaa
Page 43: Approach to hemolytic anemia naglaa

The red cell lipid composition regulates the membrane permeability to glycerol.

The added glycerol slows down the rate of water entry into the red cells.

Measure the time taken for absorbance of red cell suspension at 625 nm in glycerol to fall to half of its original value before glycerol addition (AGLT50)

Also detects autoimmune haemolytic anaemia, hereditary persistence of fetal haemoglobin, pyruvate kinase deficiency, severe glucose- 6-phosphate dehydrogenase deficiency, pregnant women (one-third), chronic renal failure on dialysis

Page 44: Approach to hemolytic anemia naglaa

Classification Trait Mild Moderate Severe

Haemoglobin (g/dl) Normal 11–15 8–12 6–8

Reticulocyte count %Normal (<3%) 3–6 >6 >10

Bilirubin (μmol/l) <17 17–34 >34 >51

Spectrin* per erythrocyte (% of normal) 100 80–100 50–80 40–60

SplenectomyNot required

Usually not necessary

Necessary before puberty

Necessary – after 6 years if possible

Page 45: Approach to hemolytic anemia naglaa
Page 46: Approach to hemolytic anemia naglaa

Symptoms of HS may appear in the perinatal period: jaundice is common in the first 2 d of life.

Some neonates with HS may be transfusion-dependent(unusual) due to their inability to mount an adequate erythropoietic response in the first year of life .

Recent evidence suggests that erythropoietin may be of benefit in reducing or avoiding transfusion, and can usually be stopped by the age of 9 months .

Children who require one or two transfusions early in life frequently become transfusion independent

Page 47: Approach to hemolytic anemia naglaa

An artifact showing ‘macrospherocytosis’ on a blood film can be produced as a result of cold storage of blood samples from patients with cryohydrocytosis, which is a variant form of hereditary stomatocytosis (‘atypical HS’)

It is particularly important to rule out stomatocytosis where splenectomy is contraindicated because of the thrombotic risk.

Atypical cases may require measurement of erythrocyte membrane proteins to clarify the nature of the membrane disorder and in the absence of a family history.

Occasionally molecular genetic analysis will help to determine whether inheritance is recessive or non-dominant.

Page 48: Approach to hemolytic anemia naglaa

Iron, folate or vitamin B12 deficiencies can mask the laboratory features.

Obstructive jaundice alters the lipid composition of the red cell membrane, masking the film appearances andreducing the haemolysis.

Co-inheritance of other haematological disorders, such as beta thalassaemia trait or SC disease, can lead to confusion in the diagnosis and variable clinical effects

.

Page 49: Approach to hemolytic anemia naglaa

AUTOIMMUNE HAEMOLYTIC ANAEMIA

hemolysis, MCV decreased

P Smear: microspherocytosis,

Confirmation: Warm Direct Coomb’s Test / Antiglobulin test

ColdDAT positive with polyspecific and anticompliment antisera

Page 50: Approach to hemolytic anemia naglaa

DAT

                               

•Sensitivity/Specificity: >99% patients with warm agglutinin AIHA will exhibit a positive result; <1% normal population have + result.

Page 51: Approach to hemolytic anemia naglaa

In some cases the density of attached autoantibody may be too low for detection by DAT. This may be resolved by flow cytometric assessment of red cell Ig density .

Polyspecific DAT reagents may also fail to detect some autoantibodies, particularly IgA, as anti-IgA is not usually incorporated into the reagent.

Application of specific anti G, A, M and complement DAT reagents may resolve some cases

Page 52: Approach to hemolytic anemia naglaa

INSERT TITLE TEXT HERE

MACROCYTE

SPHEROCYTE

IMMUNOHEMOLYTIC ANEMIA

Page 53: Approach to hemolytic anemia naglaa

CASE 5

32 yr old presented 4 days history of distention of abdomen and rt hypochondrial pain and has h/o passage of dark colored urine at night for weeks

On USG- hepatomegaly,gross ascites,hepatic vein

thrombosis Lab : Hb – 7gm%. WBC- 2200, PLC- 80,000 LDH- 600, S.BR- 4 mg% urine bile pigment +,heme dip

stick++

What is the diagnosis?

Page 54: Approach to hemolytic anemia naglaa

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Acquired chronic H.A

Persistent intra vascular hemolysis Pancytopenia Lab :HBuria,hemosiderinuria,increased LDH,bilirubin Risk of venous thrombosis C/F – hemoglobinuria during night P.S – polychromatophilia, normoblasts B.M – normoblastic hyperplasia Def.diagnosis-flow cytometry CD59-,CD55- RBC,WBC Acid haemolysis test Acid hemolysis test (PNH)A

Page 55: Approach to hemolytic anemia naglaa

Caused from a defect in the production of GPI protein anchors on the surface of all blood cell

Protect red cells from the activity of the complement system. but 2 are important in protecting red cells from destruction: CD55 (DAF) and CD59

Defect makes the red cells in particular susceptible to destruction by the complement system. Intravascular hemolytic anemia.

Page 56: Approach to hemolytic anemia naglaa

“FOOT STRIKE HEMOLYSIS”

Caused by RBC destruction from repeated trauma

• Elevated temperature in muscle, turbulence and acidosis may also be involved

Bilirubin Haptoglobin Schistocytes Slight MCV & Reticulocytes

Preferential breakdown of older rbcs Hemoglobinuria Anemia resolves w/ d/c exercise

Page 57: Approach to hemolytic anemia naglaa

THANK YOU

Page 58: Approach to hemolytic anemia naglaa

BETA THALASSEMIA

Mutn. Beta globin expression

M.C- derange splicing of m-RNA

HYPOCHROMIA ,MICROCYTIC anemia

Page 59: Approach to hemolytic anemia naglaa

AUTOIMMUNE HEMOLYTIC ANEMIA

Result from RBC destruction due to RBC autoantibodies: Ig G, M, E, A

Most commonly-idiopathic Classification

Warm AI hemolysis:Ab binds at 37 C Cold AI Hemolysis: Ab binds at 4 C

Page 60: Approach to hemolytic anemia naglaa

1.Warm AI Hemolysis: Can occurs at all age groups F > M Causes:

50% IdiopathicRest - secondary causes:

1.Lymphoid neoplasm: CLL, Lymphoma, Myeloma

2.Solid Tumors: Lung, Colon, Kidney, Ovary, Thymoma

3.CTD: SLE,RA4.Drugs: Alpha methyl DOPA, Penicillin , Quinine, Chloroquine

5. UC, HIV

Page 61: Approach to hemolytic anemia naglaa